Evidence map›Paper›PMID 26275059›Full record

ArticlePloS one2015

A Cost-Effectiveness Analysis of a Home-Based HIV Counselling and Testing Intervention versus the Standard (Facility Based) HIV Testing Strategy in Rural South Africa.

Hanani Tabana, Lungiswa Nkonki, Charles Hongoro, Tanya Doherty, Anna Mia Ekström, Reshma Naik, Wanga Zembe-Mkabile, Debra Jackson, Anna Thorson

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanani TabanaHealth Systems Research Unit, Medical Research Council of South Africa, Cape Town, South Africa; Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; School of Public Health, University of the Western Cape, Cape Town, South Africa.
Lungiswa NkonkiDivision of Community Health, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.
Charles HongoroPopulation Health, Health Systems and Innovation, Human Sciences Research Council, Pretoria, South Africa.
Tanya DohertyHealth Systems Research Unit, Medical Research Council of South Africa, Cape Town, South Africa; School of Public Health, University of the Western Cape, Cape Town, South Africa.
Anna Mia EkströmDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Reshma NaikHealth Systems Research Unit, Medical Research Council of South Africa, Cape Town, South Africa; Department of Global Health, Boston University School of Public Health, Boston, United States of America; Population Reference Bureau, 1875 Connecticut Avenue, NW Suite 520, Washington, DC, United States of America.
Wanga Zembe-MkabileHealth Systems Research Unit, Medical Research Council of South Africa, Cape Town, South Africa.
Debra JacksonSchool of Public Health, University of the Western Cape, Cape Town, South Africa.
Anna ThorsonDepartment of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is growing evidence concerning the acceptability and feasibility of home-based HIV testing. However, less is known about the cost-effectiveness of the approach yet it is a critical component to guide decisions about scaling up access to HIV testing. This study examined the cost-effectiveness of a home-based HIV testing intervention in rural South Africa.

methodsTwo alternatives: clinic and home-based HIV counselling and testing were compared. Costs were analysed from a provider's perspective for the period of January to December 2010. The outcome, HIV counselling and testing (HCT) uptake was obtained from the Good Start home-based HIV counselling and testing (HBHCT) cluster randomised control trial undertaken in KwaZulu-Natal province. Cost-effectiveness was estimated for a target population of 22,099 versus 23,864 people for intervention and control communities respectively. Average costs were calculated as the cost per client tested, while cost-effectiveness was calculated as the cost per additional client tested through HBHCT.

resultsBased on effectiveness of 37% in the intervention (HBHCT) arm compared to 16% in control arm, home based testing costs US$29 compared to US$38 per person for clinic HCT. The incremental cost effectiveness per client tested using HBHCT was $19.

conclusionsHBHCT was less costly and more effective. Home-based HCT could present a cost-effective alternative for rural 'hard to reach' populations depending on affordability by the health system, and should be considered as part of community outreach programs.

Indexed as

CounselingEarly Medical InterventionHIV-1HIV InfectionsRural PopulationCosts and Cost AnalysisFemaleHumansMaleSouth Africa

Identifiers

PMID26275059
PMCPMC4537202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.